Ernexa Therapeutics Inc [ERNA] stock is trading at $1.27, up 4.96%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ERNA shares have gain 8.55% over the last week, with a monthly amount drifted -3.05%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ernexa Therapeutics Inc [ERNA] stock has fluctuated between $1.08 and $14.40 over the past year. Ernexa Therapeutics Inc [NASDAQ: ERNA] shares were valued at $1.27 at the most recent close of the market.
Analyzing the ERNA fundamentals
Ernexa Therapeutics Inc [NASDAQ:ERNA] reported sales of 0.00M for the trailing twelve months, which represents a drop of -100.00%. Gross Profit Margin for this corporation currently stands at 418.0% with Operating Profit Margin at -9921.0%, Pretax Profit Margin comes in at -18312.0%, and Net Profit Margin reading is -18348.0%. To continue investigating profitability, this company’s Return on Assets is posted at -2.97, Equity is -19.49 and Total Capital is -2.46. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1633 points at the first support level, and at 1.0567 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3433, and for the 2nd resistance point, it is at 1.4167.
Ratios To Look Out For
For context, Ernexa Therapeutics Inc’s Current Ratio is 1.58. In addition, the Quick Ratio stands at 1.58 and the Cash Ratio stands at 1.42.
Transactions by insiders
Recent insider trading involved Cherington Charles, 10% Owner, that happened on Jun 09 ’25 when 21.24 million shares were purchased. 10% Owner, Cherington Charles completed a deal on Apr 02 ’25 to buy 3.77 million shares.
